This invention relates to an ophthalmic composition comprising a synergistic combination of glycogen and hyaluronic acid or a pharmaceutically acceptable salt thereof, and at least one pharmaceutical acceptable excipient, to a process for the preparation thereof, and to the use thereof for the treatment of dry eye syndrome.